Kohkan Shamsi

Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial

Serge Gauthier, Howard Feldman, Lon S. Schneider et al. · The Lancet · 2016 · 416 citations · Full text

Medicine, Neurology, Pharmacology +14

Diagnostic efficacy of gadoxetic acid (Primovist)-enhanced MRI and spiral CT for a therapeutic strategy: comparison with intraoperative and histopathologic findings in focal liver lesions

Renate Hammerstingl, Alexander Huppertz, Josy Breuer et al. · European Radiology · 2007 · 381 citations

Medicine, Pathology, Radiology +17

Phase II clinical evaluation of Gd-EOB-DTPA: dose, safety aspects, and pulse sequence.

Peter Reimer, EJ Rummeny, Kohkan Shamsi et al. · Radiology · 1996 · 308 citations

Medicine, Nuclear Medicine, Radiology +16

Potential of Low Dose Leuco-Methylthioninium Bis(Hydromethanesulphonate) (LMTM) Monotherapy for Treatment of Mild Alzheimer’s Disease: Cohort Analysis as Modified Primary Outcome in a Phase III Clinical Trial

Gordon Wilcock, Serge Gauthier, Giovanni B. Frisoni et al. · Journal of Alzheimer s Disease · 2017 · 217 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Preoperative evaluation of malignant liver tumors: comparison of unenhanced and SPIO (Resovist)-enhanced MR imaging with biphasic CTAP and intraoperative US

Thomas J. Vogl, W. Schwarz, Michael Pietsch et al. · European Radiology · 2003 · 138 citations

Medicine, Oncology, Radiology +14